Acta Med. 2018, 61: 125-130
https://doi.org/10.14712/18059694.2018.130
Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India – a Seven Year Ambispective Study
References
1. Bull World Health Org 2004; 82: 346–53.
JA, Luby SP, Mintz ED. The global burden of typhoid fever.
2. Miller SI, Pegues DA. Salmonella species, including Salmonella typhi. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and Practice of Infectious Disease, 4th edn. New York: Churchill Livingstone, 1998: pp. 2344–73.
3. Indian J Med Microbiol 2005; 23: 125–27.
< MN, Chowta NK. Study of clinical profile and antibiotic response in typhoid fever. https://doi.org/10.4103/0255-0857.16054>
4. J Infect Developing Countries 2008; 2(6): 454–60.
OS, Dutta S, Sur D. Epidemiology of typhoid and paratyphoid fever in India.
5. Indian Journal of Medical Research 2003; 117: 10–2.
SS, Agrawal G, Jalgaonkar SV. An unusually high occurrence of Salmonella enterica serotype Paratyphi A in patients with enteric fever.
6. Indian J Pathol Microbiol 2016; 59: 327–9.
< A, Patro S, Choudhury S, Padhee A, Das R. Emerging enteric fever due to switching biotype of Salmonella (Paratyphi A) in Eastern Odisha. https://doi.org/10.4103/0377-4929.188124>
7. BMC Public Health 2007; 7(147): 289.
< D, Ali M, von Seidlein L, et al. Comparisons of predictors for typhoid and paratyphoid fever in Kolkata, India. https://doi.org/10.1186/1471-2458-7-289>
<PubMed>
8. Epidemiol. Infect 2006; 134: 961–6.
< S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary-care hospital. https://doi.org/10.1017/S0950268805005844>
<PubMed>
9. Trans R Soc Trop Med Hyg 2008; 102: 91–5.
< AP, Basnyat B, Thwaltes GE, et al. Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993–2003. https://doi.org/10.1016/j.trstmh.2007.10.003>
10. Nature 1972; 239: 109–10.
< CKJ, Vimala KN. Transferable chloramphenicol resistance in Salmonella typhi. https://doi.org/10.1038/239109b0>
11. Antimicrob Agents Chemother 1973; 4: 597–601.
< J, Galind DE. Salmonella typhi resistant to chloramphenicol, ampicillin and other antimicrobial agents: Strains isolated during an extensive typhoid fever epidemic in Mexico. https://doi.org/10.1128/AAC.4.6.597>
12. Epidemiology and Infection 2009; 137: 266–9.
< CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype typhi in seven Asian countries. https://doi.org/10.1017/S0950268808000745>
13. Med J Armed Forces India 2016; 72 (1): 281–4.
L, Cariappa MP. Blood culture isolates and Antibiogram of Samonella: Experience of a tertiary care hospital.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty Second Informational Supplement M100-22. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute; 2012.
15. Ind J Med Microbiol 2011; 133: 431–3.
SS, Das U, Choudhury BK. Occurrence & Antibiogram Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa.
16. World Health Organization: Indian Network for Surveillance of Antimicrobial Resistance. Antibiogram of Salmonella enterica serovar Typhi and Salmonella enterica serovar Paratyphi A: a multi-centre study from India. WHO South-East Asia J Public Health 2012; 1: 182–8.
17. PLoS ONE 2014; 9(8): e101347.
< S, Das S, Mitra U, et al. Antimicrobial Resistance, Virulence Profiles and Molecular Subtypes of Salmonella enterica Serovars Typhi and Paratyphi A Blood Isolates from Kolkata, India during 2009–2013. https://doi.org/10.1371/journal.pone.0101347>
<PubMed>
18. Indian J Med Res 2009; 129: 95–8.
V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella paratyphi A in and around Chandigarh.
19. Indian J Med Microbiol 2007; 25: 78–9.
SS, Dash U. A sudden rise in occurrence of Salmonella paratyphi A infection in Rourkela Orissa.
20. J Infect Dev Ctries 2011; 5(5): 324–37.
< SA, Karande S. Multidrug resistant typhoid fever: a review. https://doi.org/10.3855/jidc.1405>
21. Frontiers in Life Science 2015; 8(3): 284–93.
E, Pusparajah P, Ab Mutalib NS, et al. Salmonella: A review on pathogenesis, epidemiology and antibiotic resistance.
22. J Assoc Physicians India 2008; 56: 237–40.
S, Soman R, Singhal T, et al. Enteric fever in Mumbai – clinical profile, sensitivity patterns and response to antimicrobials.
23. Indian J Med Res 2007; 125: 685–8.
B, Dutta S, Sur D, et al. Phage typing, biotyping & antimicrobial resistance profile of Salmonella enterica serotype Typhi from Kolkata.
24. Trop Life Sci Res 2013: 24: 45–54.
Y, Sharma A, Mani KR. Antibiogram Profile of Salmonella enterica Serovar Typhi in India – a two year study.
25. Int J Current Microbiol Appl Sci 2015: 4: 1081–6.
A, Kumar Y, Sharma A, Mani KR. Re-emergence of chloramphenicol sensitive isolates of Salmonella enterica serovar typhi isolates in India during 2013–14.
26. Tropical Medicine and International Health 2016; 21: 1255–62.
< S , Nabarro LEB, Veeraraghavan B and Rupali P. Enteric fever in India: current scenario and future directions. https://doi.org/10.1111/tmi.12762>
27. Indian J Med Microbiol 2017; 35: 61–8.
S, Sharma P, Kumari B, et al. Characterisation of antimicrobial resistance in Salmonellae during 2014–2015 from four centres across India: An ICMR antimicrobial resistance surveillance network report.
28. Indian J Med Microbiol 2016; 34: 520–5.
R, Nayyar C, Manchanda V. Six-year susceptibility trends and effect of revised Clinical Laboratory Standards Institute breakpoints on ciprofloxacin susceptibility reporting in typhoidal Salmonellae in a tertiary care paediatric hospital in Northern India.
29. J Med Microbiol 2016; 65(12): 1536–9.
< R, Prasad KN. Antimicrobial susceptibility to Azithromycin among Salmonella enteric typhi and Paratyphi A isolates from India. https://doi.org/10.1099/jmm.0.000390>
30. mBio 2018; 9: e00105–18.
< EJ, Shakoor S, Page AJ, et al. Emergence of an extensively drug resistant Salmonella enteric serovar Typhi clone harbouring a promiscuous plasmid encoding resistance to flouroquinolones and third generation cephalosporins. https://doi.org/10.1128/mBio.00105-18>
<PubMed>